SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences gets nod for liquidation of CFS Pahang Asia

11 Nov 2024 Evaluate

Camlin Fine Sciences has received approval from board of directors for liquidation of CFS Pahang Asia Pte, Subsidiary Company of the Company. CFS Pahang Asia Pte is not a material subsidiary of the Company and therefore it will not impact materially on consolidated financials of the Company. The Liquidation is expected to be completed by March 31, 2025. 

Camlin Fine Sciences (CFS) is the leading integrated manufacturer of the most preferred traditional antioxidants (Shelf Life Solutions) available.

Camlin Fine Sciences Share Price

131.85 4.88 (3.84%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×